Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Malcolm Flanagan

Working with Animal Pharm since 2010, Malcolm specializes in developing Animal Pharm’s coverage of the Asian and Middle East animal health markets, as well as covering the global rise of feed additives, emerging pathogens and aquaculture. Malcolm has profiled both established companies and smaller emerging firms.

He initially joined Informa as online news editor for agribusiness policy and legislation publication Agra Europe.

Prior to Informa, Malcolm worked for with news agencies Reuters and IPS, having studied journalism at college.
Set Alert for Articles By Malcolm Flanagan

Latest From Malcolm Flanagan

Israeli firm's peptides slow tilapia sexual maturity to make them bigger

The quest to make cultured fish healthier, stronger and bigger continues apace. An Israeli company believes it has found a way to unlock the real wealth of tilapia using peptide technology in feed. Animal Pharm analyst Malcolm Flanagan spoke to AquiNovo's chief executive Dr Nissen Chen about his firm's aquaculture ambitions. 

Aquaculture R&D

NZ to cull 4,000 cattle to limit Mycoplasma bovis spread

New Zealand is taking further measures to curb the impact of an outbreak of Mycoplasma bovis in the country's South Island.

New Zealand Bovine

Funding will help Moredun test poultry mite vaccines

Scotland's Moredun Research Institute has received a cash boost to test vaccines for reducing damaging red mites in poultry production using fewer chickens.

Vaccines Poultry

Genetic progress in ASF vaccine research

A significant achievement in the search for a vaccine for the economically damaging African swine fever (ASF) has been claimed by Australian and US researchers. 

R&D Vaccines

Rabies vaccination has unexpected benefits

A US veterinary foundation claims that vaccinating dogs against rabies can have multiple health benefits for animals and potentially humans.

South Africa Vaccines

Delacon expands phytogenics team in US

Austrian feed additive specialist Delacon has increased its potential penetration in the US market with the addition of two new technical sales experts.

United States People
See All